Early prediction of life-threatening arrhythmias in non-ST elevation myocardial infarction – does it change clinical practice?

Zorzi A , et al. At admission risk stratification for in-hospital life-threatening ventricular arrhythmias and death in non-ST elevation myocardial infarction patients. Eur Heart J Acute Cardiovasc Care 2014; in press. [Epub ahead of print].

Al-Khatib SM Granger CB Huang Y , et al. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: Incidence, predictors, and outcomes. Circulation 2002; 106: 309–312.

Piccini JP White JA Mehta RH , et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation 2012; 126: 41–49.

Mehta RH Harjai KJ Grines L , et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: Incidence, predictors, and outcomes. J Am Coll Cardiol 2004; 43: 1765–1772.

Hamm CW Bassand JP Agewall S , et al.; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999–3054.

Hohnloser SH Kuck KH Dorian P , et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481–2488.

Steinbeck G Andresen D Seidl K , et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009; 361: 1427–1436.

Newby KH Thompson T Stebbins A , et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: Incidence and outcomes. Circulation 1998; 98: 2567–2573.

Berger PB Ruocco NA Ryan TJ , et al. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: Results from the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. J Am Coll Cardiol 1993; 22: 1773–1779.

Mehta RH Harjai KJ Grines L , et al.; Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: Incidence, predictors, and outcomes. J Am Coll Cardiol 2004; 43: 1765–1772.

Rahimi K Watzlawek S Thiele H , et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J 2006; 27: 1706–1711.